Multiple Sclerosis Center Advances Knowledge of MS
Posted on Tue, Jan 10, 2012 @ 11:03 AM
One of the benefits of a multi-disciplinary Multiple Sclerosis Center is the knowledge and expertise that is accumulated and shared with others. MidAmerica Neuroscience Institute’s MS Center has operated in the Kansas City area for over 15 years and has approximately 1,000 MS patients in its care. The Institute provides many services to people with Multiple Sclerosis (MS), their family members, as well as other health care professionals involved in treating MS. On the front lines of educating patients, the public and medical providers is
Doug Schell. Schell is Clinical Nurse Specialist and MS Certified Nurse at the Institute and his knowledge and experience of Multiple Sclerosis is increasingly in demand.
In December Schell traveled to Wichita, KS to meet with a group of people with MS and their family members. Schell presented them with information about MS and the MS medicine Avonex, followed by an extensive question and answer session. Also in December he presented a talk to local health care providers about the experimental medications Rituximab and Ocrealizumab. The Institute was part of a preliminary study on Rituximab and is currently conducting two research studies about Ocrealizumab. Interested patients can contact our research foundation for more information. In January, Schell presented local MS patients with information about Mulitiple Sclerosis and the first oral drug approved for MS, Gilenya, at an evening meeting at a local restaurant. The Institute plans to continue to reach out to the community to provide education and information to help people with Multiple Sclerosis.